Human clinical trial of NIH-developed dengue vaccine begins

After more than a decade of development at the National Institutes of Health, a vaccine to prevent infection by the mosquito-borne dengue virus has begun human clinical testing. The vaccine was developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID) and is undergoing clinical study at the Johns Hopkins Bloomberg School of Public Health in Baltimore.

View full post on National Institutes of Health (NIH) News Releases

Asthma cancer claims unfounded – NHS Choices


MedIndia

Asthma cancer claims unfounded
NHS Choices
Asthma pumps “may increase the risk of prostate cancer”, says the Daily Mail. The newspaper says that asthma sufferers who regularly use an inhaler to ease
Asthma inhalers 'linked to prostate cancer risk'Telegraph.co.uk
Asthma inhalers 'up prostate cancer risk'Sify
Asthmatics on steroids face prostate cancer riskTimes of India
TheMedGuru –Pulse –International Business Times AU
all 29 news articles »

View full post on asthma – Google News

Asthmatics Allergy Shots Aides Some Problematic For Others – allvoices


Biomed Middle East

Asthmatics Allergy Shots Aides Some Problematic For Others
allvoices
Around 30% of asthma patients have increased breathing after having a series of injections which make their immune systems less
Allergy shots useful for asthmatics, not othersTimes of India
Study finds allergy shots can be asthma reliefInternational Business Times AU

all 17 news articles »

View full post on asthma – Google News